Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (281-290 of 378) with videos related to

Pageof 38
Sort By:
The American Journal of Pathology|August 20, 2014
Evidence that meningeal mast cells can worsen stroke pathology in miceAhmet Arac, Michele A Grimbaldeston, Andrew R B Nepomuceno, et al.
Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.
Trials|December 31, 2015
Exploring the role and function of trial steering committees: results of an expert panel meetingNicola L Harman, Elizabeth J Conroy, Steff C Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 6, 2025
Testing a 5-fraction Simultaneous Integrated Boost in Radiotherapy for Breast Cancer: The UK FAST-Forward Boost Trial Opens to RecruitmentA M Kirby, F H Cafferty, K Poole, et al.
Brain : a Journal of Neurology|May 28, 2011
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brainRobert H Andres, Nobutaka Horie, William Slikker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
<i>ESR1</i> Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT TrialsNicholas C Turner, Claire Swift, Lucy Kilburn, et al.
The Lancet. Oncology|July 5, 2011
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.
The Lancet. Oncology|November 5, 2020
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trialIan Smith, John Robertson, Lucy Kilburn, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037)Susana Banerjee, Holly Tovey, Rebecca Bowen, et al.
Pageof 38

Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
The American Journal of Pathology|August 20, 2014
Evidence that meningeal mast cells can worsen stroke pathology in miceAhmet Arac, Michele A Grimbaldeston, Andrew R B Nepomuceno, et al.
Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.
Trials|December 31, 2015
Exploring the role and function of trial steering committees: results of an expert panel meetingNicola L Harman, Elizabeth J Conroy, Steff C Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 6, 2025
Testing a 5-fraction Simultaneous Integrated Boost in Radiotherapy for Breast Cancer: The UK FAST-Forward Boost Trial Opens to RecruitmentA M Kirby, F H Cafferty, K Poole, et al.
Brain : a Journal of Neurology|May 28, 2011
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brainRobert H Andres, Nobutaka Horie, William Slikker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
<i>ESR1</i> Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT TrialsNicholas C Turner, Claire Swift, Lucy Kilburn, et al.
The Lancet. Oncology|July 5, 2011
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.
The Lancet. Oncology|November 5, 2020
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trialIan Smith, John Robertson, Lucy Kilburn, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037)Susana Banerjee, Holly Tovey, Rebecca Bowen, et al.
Pageof 38